ABOUT US
WHO WE ARE
THE TEAM
Joana Simões Correia
Renato Cardoso
Luisa Marques
Inês Coelho
Filipe Duarte
Silvia Rodrigues
Cláudia Gomes
Ricardo Neves
News
Exogenus Therapeutics featured in article on Exosome Technology
Exosome Companies – Tiny Exosomes, Enormous Potential “Recently, exosomes have been gaining momentum as a novel strategy for accessing the therapeutic effects of stem cells without the risks and difficulties of administering the cells to patients. Exosome companies are multiplying in number, with new market entrants popping up rapidly.” in BioInformant
Exogenus Therapeutics participates in Cord Blood World Europe 2017
Joana Correia, Executive Director and Chief Scientific Officer presented last week at Cord Blood World Europe. Under the theme: “Umbilical cord blood supply for the development of Exo-Wound, an exosome-based product for chronic wounds” Joana talked about the technology behind Exo-Wound and the advantages and challenges of using exosomes as a therapeutic tool but also about[…]
Exogenus Therapeutics finalist at 2nd EWMA Wound Care Innovation Symposium
Exogenus Therapeutics was one of the three finalist projects of the EWMA Alira Health 2nd Wound Care Innovation Symposium that took place on May 4th, at the European Wound Management Association Conference in Amsterdam. Having the opportunity to present its innovative technology to industry leaders and clinicians during this recognized international forum was part of the[…]
Joana Simões Correia selected as a Young Transatlantic Innovation Leader 2017
It was announced last week that Joana Simões Correia, the Executive Director of Exogenus Therapeutics (Exo-T) is one of the Young Transatlantic Innovation Leaders of 2017. The Young Transatlantic Innovative Leaders Initiative Fellowship is the flagship program of the Young Transatlantic Innovation Leaders Initiative (YTILI) of the U.S. Department of State and is supported in[…]
Exo-T is recruiting
EDITAL PARA A ATRIBUIÇÃO DE BOLSA Bolsa de Doutoramento (1) Encontra-se aberto concurso para a atribuição de uma Bolsa de Doutoramento no âmbito do projeto interno: “Desenvolvimento de um medicamento biológico para tratamento de feridas da pele” da Exogenus Therapeutics, nas seguintes condições: Área Científica: Engenharia Biomédica Requisitos de admissão: Serão admitidos a concurso os[…]
Exogenus Therapeutics winner of the Everis Foundation Award 2016
It was announced today that Exogenus Therapeutics (Exo-T) is the winner of the Everis Foundation Award 2016. The award, which every year distinguishes projects from Industry, Biotechnology & Health, and Digital Economy originating from countries where the Everis Group has operations, counted in this XV edition with more than 600 applications from 10 different countries.[…]
Exogenus Therapeutics to receive support from Horizon 2020’s SME Instrument Phase 1
Exogenus Therapeutics (Exo-T) is one of the selected SMEs to receive support from the European Commission under the Horizon 2020’s SME Instrument Phase 1. With the SME Instrument, the European Commission aims to support high growth, highly innovative European SMEs with global ambitions and with a mission to disrupt existing markets. This is a highly[…]
Exo-T finalists of the Everis Foundation Award 2016
Exo-T are proud to have been chosen as one of the 6 finalists of the Everis Foundation Award 2016. Selected among 600 projects of the areas of Industry, Biotechnology & Health and Digital, Exo-T is the only Portuguese representative left in the run-up to the final, taking place in September. It has been a great[…]
The team is growing! Renato Cardoso is our new Head of Laboratory
Renato Cardoso is the new member of Exogenus Therapeutics’ team. Renato is graduated in Chemistry, Master in Advanced Chemistry, and a PhD in Chemistry, with specialization in Biological Chemistry by the University of Coimbra.
Exogenus Therapeutics at Sic Noticias
Watch Joana Correia’s interview on Sic Noticias Edição da Manhã talking about Exo-T! http://goo.gl/tLVSB9